| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/11/2005 | EP1529045A2 New compounds |
| 05/11/2005 | EP1529042A1 Arylamides |
| 05/11/2005 | EP1528925A1 Quinazoline derivatives for use in the treatment of cancer |
| 05/11/2005 | CN1615300A Benzimidazole derivatives and their use as GNRH antagonists |
| 05/11/2005 | CN1615296A Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 05/10/2005 | US6890947 (S)-3-(1-(2-(2-chloro-phenyl)-5-methyl-oxazol-4-ylmethyl)-1H -indol-5-yl)-2-ethoxy-propionic acid; peroxisome proliferator activated receptors (PPARs) |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890935 Pharmaceutical compositions and methods for use |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890924 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 05/10/2005 | US6890916 Indole derivatives useful for the treatment of CNS disorders |
| 05/10/2005 | CA2246753C Non-peptidyl vasopressin v1a antagonists |
| 05/10/2005 | CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use |
| 05/06/2005 | WO2005040345A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | WO2005040159A1 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 05/06/2005 | WO2005040158A1 1-′(e)-2-(phenyl) ethenyl-4-(arylalkoxy)-oxazole or - thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer |
| 05/06/2005 | WO2005040157A2 Novel mch receptor antagonists |
| 05/06/2005 | WO2005040152A1 Heteroyclylphenyl-and heterocyclylpyridyl-substituted azolecarboxamides as herbicides |
| 05/06/2005 | WO2005040144A1 Novel compounds |
| 05/06/2005 | WO2005040142A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 05/06/2005 | WO2005040139A2 2-aminoaryloxazole compounds as tyrosine kinase inhibitors |
| 05/06/2005 | WO2005040136A1 Piperazine derivatives and their use as modulators of nuclear hormone receptor function |
| 05/06/2005 | WO2005040129A2 Ccr3 receptor antagonists |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005040110A1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2005 | WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors |
| 05/06/2005 | WO2005039496A2 Inhibitors of cathepsin s |
| 05/06/2005 | WO2005030753A3 Therapeutic agents useful for treating pain |
| 05/06/2005 | WO2005028443A3 Protein tyrosine kinase enzyme inhibitors |
| 05/06/2005 | WO2005009949A3 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/06/2005 | WO2005005395A3 Arylamine-substituted quinazolinone compounds |
| 05/06/2005 | WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | WO2004082638A3 Histone deacetylase inhibitors |
| 05/06/2005 | CA2543419A1 Ccr3 receptor antagonists |
| 05/06/2005 | CA2542963A1 Inhibitors of cathepsin s |
| 05/06/2005 | CA2542522A1 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer |
| 05/06/2005 | CA2542220A1 Novel mch receptor antagonists |
| 05/06/2005 | CA2541989A1 P70s6 kinase modulators and method of use |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | CA2539726A1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 05/06/2005 | CA2539720A1 1-.prime.(e)-2-(phenyl) ethenyl-4-(arylalkoxy)-oxazole or - thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096382 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof |
| 05/05/2005 | US20050096375 through augmentation of glutamatergic neurotransmission; Central nervous system disorders, cognitive disorders, schizophrenia, dementia; 3-aza-bicyclo[3.1.0]hexanes; Thiophene-2-carboxylic acid (3-cyclohexylmethyl-3-aza-bicyclo[3.1.0]hex-6-ylmethyl)-(3-fluoro-4-morpholin-4-yl-phenyl)-amide |
| 05/05/2005 | US20050096368 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 05/05/2005 | US20050096363 Activator of peroxisome proliferator-activated receptor delta |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096344 controlling signal transduction; anticancer agents; antitumor agents; angiogenesis inhibitors; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents; antiischemic agents |
| 05/05/2005 | US20050096343 pharmocophores of quinolone and oxazolidinone chemicaly linked; against a variety of multi-drag resistant bacteria; staphylococci, enterococci, Moraxella catarrhalis, haemophilus influenza, bacteroides, Clostridia, Mycobacterium tuberculosis, Mycobacterium avium |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050096315 Fluorinated resorufin compounds and their application |
| 05/05/2005 | US20050096312 Antiserotonine agents; antidepressants; eating disorders; anxiolytic agents; sleep disorders; gastrointestinal disorders; cardiovascular disorders; muscular disorders; endocrine system diseases; muscular disorders; psychological disorders |
| 05/05/2005 | US20050096309 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1528059A2 Substituted isoxazoles for the treatment of inflammation |
| 05/04/2005 | EP1527069A2 Pyridines and pyrimidines substituted by 4-trifluoromethylpyrazolyl |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 05/04/2005 | EP1527049A2 Fused heterocyclic compounds as peptidase inhibitors |
| 05/04/2005 | EP1527048A2 N- phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP0886637B9 Inhibitors of microsomal triglyceride transfer protein and method |
| 05/04/2005 | CN1612868A Ethylene derivative and use as phophatidase |
| 05/04/2005 | CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/04/2005 | CN1199956C Oxadiazole derivs. having anticancer effects |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/03/2005 | US6888003 Method for producing 7-(pyrazole-3-yl) benzoxazoles |
| 05/03/2005 | US6887995 Reacting N-aryl-O-alkylcarbamate with an amide derivative in the presence of a lithium cation, a base, and a nucleophile |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | CA2236677C 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinone derivatives, their preparation and their use as anti-bacterial agents |
| 05/03/2005 | CA2236208C Substituted sulphonylamino (thio)carbonyl compounds as herbicides |
| 05/03/2005 | CA2089767C Pyridinyl thiadiazolyl- and oxadiazolyl derivatives |
| 04/28/2005 | WO2005037830A1 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2005 | WO2005037829A1 1,3-benzoxazolyl derivatives as kinase-inhibitors |
| 04/28/2005 | WO2005037828A1 Novel inhibitors of dpp-iv, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 04/28/2005 | WO2005037826A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | WO2005037803A1 Organic compounds |
| 04/28/2005 | WO2005037797A1 Substituted pyrazole urea compounds for the treatment of inflammation |
| 04/28/2005 | WO2005037796A1 Compounds and methods for treating dyslipidemia |
| 04/28/2005 | WO2005037273A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037257A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | WO2005037239A2 Use of a compound from the group of heterodiazoles or a salt of said compound, cosmetic or therapeutic formulation containing said compound or salt, said compound or salt as a therapeutic agent, and said salt |
| 04/28/2005 | WO2005037216A2 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 04/28/2005 | WO2005037199A2 Pyrazole derivatives as cannabinoid receptor modulators |
| 04/28/2005 | WO2005019168A3 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 04/28/2005 | WO2005016921A3 Novel oxazoles, their manufacture and use as pharmaceutical agents |
| 04/28/2005 | WO2005014517A3 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/28/2005 | WO2005005398A3 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 04/28/2005 | WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/28/2005 | WO2004065539A3 Androgen receptor antagonists |
| 04/28/2005 | WO2004014844A3 Aryl and heteroaryl compounds and methods to modulate coagulation |